Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SMS LIFESCIENCES INDIA vs ACTAVIS (US) - Comparison Results

ACTAVIS (US)
   Change

Actavis, Inc. is a global, integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products. It develops, manufactures and market generic, branded generic, legacy brands and Over... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 SMS LIFESCIENCES INDIA   ACTAVIS
EQUITY SHARE DATA
    SMS LIFESCIENCES INDIA
Mar-23
ACTAVIS
Dec-18
SMS LIFESCIENCES INDIA/
ACTAVIS
5-Yr Chart
Click to enlarge
High Rs94816,126-   
Low Rs50110,818-   
Sales per share (Unadj.) Rs903.83,955.8-  
Earnings per share (Unadj.) Rs37.7-1,274.2-  
Cash flow per share (Unadj.) Rs73.4416.9-  
Dividends per share (Unadj.) Rs1.500-  
Avg Dividend yield %0.20-  
Book value per share (Unadj.) Rs558.316,315.7-  
Shares outstanding (eoy) m3.02332.60-   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x0.83.4 23.6%   
Avg P/E ratio x19.2-10.6 -182.1%  
P/CF ratio (eoy) x9.932.3 30.6%  
Price / Book Value ratio x1.30.8 157.3%  
Dividend payout %4.00-   
Avg Mkt Cap Rs m2,1904,480,758 0.0%   
No. of employees `000NA16.9 0.0%   
Total wages/salary Rs m4340-   
Avg. sales/employee Rs Th077,851.4-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th0-25,076.0-  
INCOME DATA
Net Sales Rs m2,7301,315,689 0.2%  
Other income Rs m3125,160 0.1%   
Total revenues Rs m2,7601,340,849 0.2%   
Gross profit Rs m31234,478 0.9%  
Depreciation Rs m108562,428 0.0%   
Interest Rs m6975,923 0.1%   
Profit before tax Rs m166-578,713 -0.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0147,595 0.0%   
Tax Rs m52-7,334 -0.7%   
Profit after tax Rs m114-423,784 -0.0%  
Gross profit margin %11.42.6 435.9%  
Effective tax rate %31.41.3 2,480.3%   
Net profit margin %4.2-32.2 -12.9%  
BALANCE SHEET DATA
Current assets Rs m1,626539,627 0.3%   
Current liabilities Rs m1,371477,372 0.3%   
Net working cap to sales %9.44.7 197.8%  
Current ratio x1.21.1 105.0%  
Inventory Days Days920 44.8%  
Debtors Days Days61666 928.9%  
Net fixed assets Rs m2,358148,929 1.6%   
Share capital Rs m300-   
"Free" reserves Rs m1,6560-   
Net worth Rs m1,6865,426,601 0.0%   
Long term debt Rs m5491,910,903 0.0%   
Total assets Rs m3,9848,483,012 0.0%  
Interest coverage x3.4-6.6 -51.6%   
Debt to equity ratio x0.30.4 92.5%  
Sales to assets ratio x0.70.2 441.7%   
Return on assets %4.6-4.1 -111.7%  
Return on equity %6.7-7.8 -86.4%  
Return on capital %10.5-4.8 -216.8%  
Exports to sales %36.50-   
Imports to sales %26.40-   
Net fx Rs m2730-   
CASH FLOW
From Operations Rs m147470,046 0.0%  
From Investments Rs m-313258,229 -0.1%  
From Financial Activity Rs m169-806,740 -0.0%  
Net Cashflow Rs m3-78,073 -0.0%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ACTAVIS (US) is United States Dollars. All data has been converted at 83.34 Rs / USD

Compare SMS LIFESCIENCES INDIA With: ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  

Compare SMS LIFESCIENCES INDIA With: ZIM LABORATORIES  SANJIVANI PA  NUTRAPLUS PR  IOL CHEMICALS & PHARM.  ANUH PHARMA  



Today's Market

Sensex Today Trades Flat | Nifty Below 22,350 | Kotak Mahindra Bank Tanks 9% Sensex Today Trades Flat | Nifty Below 22,350 | Kotak Mahindra Bank Tanks 9%(10:30 am)

Asian stocks fell on Thursday as disappointing earnings forecasts from Facebook parent Meta Platforms hammered tech shares, while the yen's slump past 155 per dollar.